
NEOPHOTONICS CORPORA
![]() |
|
12.24USD | -0.81% |
NEOPHOTONICS CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
11/02/2020 | 04:21pm |
ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On
financial results for the third quarter ended
Company's press release is furnished and attached as Exhibit 99.1 to this Form
8-K.
The information contained in this Item 2.02, including Exhibit 99.1 hereto,
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or subject to the
liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of
1933, as amended (the "Securities Act"), and shall not be incorporated by
reference in any registration statement or other document filed under the
Securities Act or the Exchange Act, whether made before or after the date
hereof, regardless of any general incorporation language in such filings, except
as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit Number Description
99.1 Press Release issued by
2, 2020
third quarter ended
104 Cover Page Interactive Data File (embedded within the Inline
XBRL document)
--------------------------------------------------------------------------------
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date:
By: /S/
Senior Vice President, Finance and
Chief Financial Officer
(Principal Financial and
Accounting Officer)
© Edgar Online, source